Why Data-Driven Success Demands More Than Quick Wins With Vikas Mahajan

The pharmaceutical industry is undergoing a significant transformation, fueled by the integration of AI and data-driven technologies. These innovations hold the promise of revolutionizing everything from personalized medicine to drug discovery and patient engagement. However, amidst the excitement surrounding these advancements, leaders must be cautious of the risks posed by jumping into AI adoption without fully understanding its potential or limitations. In this interview, Vikas Mahajan, Head of Data and Analytics at Indegene, offers valuable insights on how pharmaceutical organizations can navigate the complexities of AI, avoid common pitfalls, and ensure that their AI investments align with long-term business goals.

With over 20 years of experience in data strategy, AI, and machine learning, Vikas has led numerous client-facing teams across diverse industries, with a particular focus on healthcare and life sciences. He has worked closely with organizations to develop AI frameworks that foster innovation, drive business value, and address the sector's most pressing challenges.

Key Highlights:

Avoiding AI Hype: Vikas stresses the need for pharma leaders to focus on the real business value of AI and avoid getting caught up in the allure of trendy technologies that may not yield meaningful results.

Data Quality is Key: According to Vikas, the foundation of successful AI initiatives lies in high-quality, well-governed data. Without accurate and comprehensive data, AI-driven insights cannot be trusted to drive informed decision-making.